LivaNova (United States)

Recent papers from LivaNova (United States)

1. Association of clinical characteristics to mortality in acute respiratory failure patients treated with ECCO ₂ RThe International Journal of Artificial Organs · 2026
2. iPad Eye Tracking Reproduces Clinical Grade Oculomotor Differences in Parkinson’s Diseasenpj Digital Medicine · 2026
3. Vagal Nerve Stimulation in Patients With Heart Failure and Reduced Ejection FractionJournal of the American College of Cardiology · 2026
4. Vagus Nerve Stimulation Therapy for Epilepsy: Mechanisms of Action and Therapeutic ApproachesBrain Sciences · 2025
5. Specialized AI and neurosurgeons in niche expertise: a proof-of-concept in neuromodulation with vagus nerve stimulationActa Neurochirurgica · 2025
6. Prevalence of sympathetic fibers within the rat cervical vagus, and functional consequence on physiological effects mediated by vagus nerve stimulation (VNS)2025
7. Resting‐state functional connectivity changes with microburst vagus nerve stimulation therapyEpilepsia Open · 2025
8. Vagus nerve stimulation in Lennox–Gastaut syndrome: Twenty‐four‐month data and experience from the CORE ‐ VNS studyEpilepsia · 2025
9. Electroencephalography based Delirium Detection in Acute Stroke2024
10. Update on the assessment of resistance to antidepressant treatment: Rationale for the Antidepressant Treatment History Form: Short Form-2 (ATHF-SF2)Journal of Psychiatric Research · 2024
11. Resting-state Functional Connectivity Changes with Microburst VNS Therapy Differ Between Focal and Generalized Epilepsy (P3-1.010)Neurology · 2024
12. Optimized microburst VNS elicits fMRI responses beyond thalamic‐specific response from standard VNSAnnals of Clinical and Translational Neurology · 2024
13. Compatibility of Standard Vagus Nerve Stimulation and Investigational Microburst Vagus Nerve Stimulation Therapy with fMRIAmerican Journal of Neuroradiology · 2024
14. Feasibility study of microburst VNS therapy in drug-resistant focal and generalized epilepsyBrain stimulation · 2024
15. Extracorporeal Carbon Dioxide Removal With the Hemolung in Patients With Acute-on-Chronic Respiratory Failure: A Multicenter Retrospective Cohort StudyASAIO Journal · 2024
16. Extracorporeal Carbon Dioxide Removal to Avoid Invasive Ventilation During Exacerbations of Chronic Obstructive Pulmonary Disease: VENT-AVOID Trial – A Randomized Clinical TrialAmerican Journal of Respiratory and Critical Care Medicine · 2024
17. Breaking Down Barriers to Transcatheter Aortic Valve ReplacementJournal of the Society for Cardiovascular Angiography & Interventions · 2024
18. Genome-wide p63-Target Gene Analyses Reveal TAp63/NRF2-Dependent Oxidative Stress ResponsesCancer Research Communications · 2024
19. Assumptions and statistical inferenceEpilepsia · 2023
20. Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: II. Sensitivity to treatment effectsAustralian & New Zealand Journal of Psychiatry · 2023